Work

Cancer vaccines

Year: 2022

Type: article

Source: Cancer Cell

DOI: 10.1016/j.ccell.2022.05.015

Authors: John T. Schiller, Douglas R. Lowy, Ian H. Frazer, Olivera J. Finn, Eduardo Vilar, H. Kim Lyerly, Sacha Gnjatic, Neeha Zaidi, Patrick A. Ott, Vinod P. Balachandran, Pierre-Yves Dietrich, Denis Migliorini, Robert H. Vonderheide, Susan M. Domchek

Institution: National Cancer Institute

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Amgen, Bristol-Myers Squibb, Pfizer, AstraZeneca, GlaxoSmithKline, Merck, Novartis, University of Pennsylvania, Celldex Therapeutics, University of Queensland, Université de Genève, LG Chem, Genentech, National Cancer Institute, Janssen Research and Development

Awards: G1049200415, G1324540468, G1733189847, G4847734291, G6033587094, Immunoprevention and immunosurveillance of human non-viral cancers

OpenAlex ID: W4282583865

FWCI: 2.986

Cites:

Cited by: 45

Related to: 10